3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia
52
Leukemia, Myeloid, Acute
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
28
Lymphoma
23
Burkitt Lymphoma
16
Leukemia, Monocytic, Acute
15
Leukemia, Myelomonocytic, Acute
14
Leukemia, Megakaryoblastic, Acute
14
Leukemia, Erythroblastic, Acute
14
Congenital Abnormalities
12
Leukemia, Biphenotypic, Acute
9
Myelodysplastic Syndromes
7
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Leukemia, Eosinophilic, Acute
4
Hodgkin Disease
4
Dendritic Cell Sarcoma, Interdigitating
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Follicular
3
Leukemia, Basophilic, Acute
3
Anemia, Refractory, with Excess of Blasts
3
Waldenstrom Macroglobulinemia
2
Recurrence
2
Neutropenia
2
Myeloproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Interventions
Razoxane
4
Doxorubicin
4
Dexrazoxane
4
Vincristine
3
Etoposide
3
Radiotherapy
2
Prednisone
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Bleomycin
2
hydrocortisone hemisuccinate
1
Watchful Waiting
1
Trastuzumab
1
Proton Therapy
1
Observation
1
Mercaptopurine
1
Leucovorin
1
Ifosfamide
1
Hydrocortisone
1
Enalapril
1
Cytarabine
1
Cyclophosphamide
1
Cisplatin
1
Carvedilol
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Cardiotoxicity
×
Cytarabine
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled